Cytodyn Financial Statements From 2010 to 2022

CYDY
 Stock
  

USD 0.41  0.01  2.38%   

Cytodyn financial statements provide useful quarterly and yearly information to potential Cytodyn investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cytodyn financial statements helps investors assess Cytodyn's valuation, profitability, and current liquidity needs.
Cytodyn does not presently have any fundamental signals for analysis.
.
  
Check Cytodyn financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytodyn main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Cytodyn financial statements analysis is a perfect complement when working with Cytodyn Valuation or Volatility modules. It can also supplement various Cytodyn Technical models . Continue to the analysis of Cytodyn Correlation against competitors.

Cytodyn Working Capital Analysis

Cytodyn's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Working Capital 
 = 
Current Assets 
Current Liabilities 
More About Working Capital | All Equity Analysis

Current Cytodyn Working Capital

    
  (371.16 K)  
Most of Cytodyn's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cytodyn is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Compare to competition

In accordance with the company's disclosures, Cytodyn has a Working Capital of (371,157). This is 100.09% lower than that of the Healthcare sector and 100.07% lower than that of the Biotechnology industry. The working capital for all United States stocks is 100.03% higher than that of the company.

Cytodyn Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cytodyn's current stock value. Our valuation model uses many indicators to compare Cytodyn value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cytodyn competition to find correlations between indicators driving Cytodyn's intrinsic value. More Info.
Cytodyn is number one stock in current liabilities category among related companies. It is number one stock in cash flow from operations category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cytodyn by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cytodyn's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cytodyn's earnings, one of the primary drivers of an investment's value.

About Cytodyn Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Cytodyn income statement, its balance sheet, and the statement of cash flows. Cytodyn investors use historical funamental indicators, such as Cytodyn's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cytodyn investors may use each financial statement separately, they are all related. The changes in Cytodyn's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cytodyn's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cytodyn Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cytodyn. Please read more on our technical analysis and fundamental analysis pages.
CytoDyn Inc. operates as a late-stage biotechnology company. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington. Cytodyn operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 24 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cytodyn in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cytodyn's short interest history, or implied volatility extrapolated from Cytodyn options trading.

Pair Trading with Cytodyn

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytodyn position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytodyn will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Cytodyn could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytodyn when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytodyn - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytodyn to buy it.
The correlation of Cytodyn is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytodyn moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytodyn moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytodyn can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to the analysis of Cytodyn Correlation against competitors. Note that the Cytodyn information on this page should be used as a complementary analysis to other Cytodyn's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Cytodyn OTC Stock analysis

When running Cytodyn price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Is Cytodyn's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytodyn. If investors know Cytodyn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytodyn listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cytodyn is measured differently than its book value, which is the value of Cytodyn that is recorded on the company's balance sheet. Investors also form their own opinion of Cytodyn's value that differs from its market value or its book value, called intrinsic value, which is Cytodyn's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytodyn's market value can be influenced by many factors that don't directly affect Cytodyn's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytodyn's value and its price as these two are different measures arrived at by different means. Investors typically determine Cytodyn value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytodyn's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.